Request a proposal
Home / Industries / Medical devices & life sciences
Life sciences

Medical devices & life sciences

Valuation, purchase accounting, equity-compensation, and reporting support for medical-device, life-sciences, biotechnology, and diagnostics companies.

How we help

Common accounting advisory and valuation needs.

Business Valuation Consulting Business valuation, tax valuation, financial modeling, statistical analysis, litigation support, and related economic consulting. Purchase price allocation — ASC 805 ASC 805 purchase accounting, opening balance sheet support, and fair-value measurement for acquired assets and liabilities. Stock-based compensation — 409A / ASC 718 409A common-stock valuations, ASC 718 support, and complex capital-structure waterfall analyses. Audit readiness Review trial balances, surface support gaps, and resolve issues that delay audit completion.
Representative engagements

Examples of related client work.

ASC 842 Lease Implementation

Vitalant

Blood & Biotherapies (Non-Profit) Non-Profit

R&M was engaged to lead Vitalant's ASC 842 lease implementation, addressing a large, geographically distributed lease portfolio spanning donor centers, mobile collection facilities, laboratory space, and corporate offices. Work included data abstraction, classification, and right-of-use/lease-liability calculation.

View case
Valuation — ASC 718 / ASC 805

Confluent Medical Technologies

Medical Device Manufacturing (Nitinol, Catheters, Implants) Private

R&M has served as Confluent's technical-accounting partner since 2019, supporting ASC 480 debt-instrument analyses across multiple capital structure events, ASC 815 embedded-derivative identification and bifurcation, ASC 606 revenue recognition, ASC 842 lease accounting, and ongoing acquisition support. Valuation services engagement covering ASC 718 / ASC 805 for financial reporting under U.S. GAAP. R&M prepared valuation analyses, supporting models, and written deliverables for management and external-auditor review.

View case
ASC 480 Debt

Providence Medical Technology

Medical Device — Spine Venture-Backed

R&M leads Providence's IPO-readiness program, addressing ASC 480 debt instrument classification, ASC 606 revenue recognition refresh, ASC 842 lease accounting, ASC 718 equity compensation, and SOX 404 control environment design.

View case
Capitalized Software (ASC 350-40)

LifeScience Logistics

Pharmaceutical 3PL & Distribution PE-Backed

R&M delivered capitalized software accounting analyses under ASC 350-40 for internally developed cold-chain platform software, alongside ASC 606 revenue recognition memos for warehousing, fulfillment, and value-added services.

View case
ASC 805 Acquisition

Axonics

Medical Device — Sacral Neuromodulation Acquired

R&M supported Axonics across SOX 404 program design and testing through multiple fiscal years, ASC 326 CECL implementation, the Contura acquisition purchase accounting, and ongoing SEC compliance.

View case
SOX 404 Multi-Year

Pro-Dex

Medical Device Manufacturing Public Company

R&M has served as Pro-Dex's SOX 404 compliance partner for 10+ consecutive fiscal years, supporting annual risk assessment, control design and testing, deficiency aggregation, and remediation across the company's SEC reporting program.

View case
Engage

Need accounting advisory or valuation support in this industry?

We will connect you with a partner who understands the reporting, transaction, and audit context.

Speak with us